Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134164) titled 'Study on the effectiveness of Hexagonal Optimized Refractive Integration (HORI) spectacles for preventing myopia onset in pre-myopia children' on Oct. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second People's Hospital of Foshan
Condition:
Myopia,premyopia
Intervention:
HORI group:Wear HORI spectacles daily. The spectacles should be worn continuously for 12 months except during sleep and bathing.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-05-25
Target Sample Size: HORI group:163;Control group:163;
Countries of Recruitment:
Chi...